Avalon Globocare Corp's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 155/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Avalon Globocare Corp's Score
Industry at a Glance
Industry Ranking
155 / 206
Overall Ranking
472 / 4562
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Avalon Globocare Corp Highlights
StrengthsRisks
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.33M.
Overvalued
The company’s latest PE is -0.16, at a high 3-year percentile range.
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Ticker SymbolALBT
CompanyAvalon Globocare Corp
CEOJin (David)
Websitehttps://www.avalon-globocare.com/
FAQs
What is the current price of Avalon Globocare Corp (ALBT)?
The current price of Avalon Globocare Corp (ALBT) is 1.260.
What is the symbol of Avalon Globocare Corp?
The ticker symbol of Avalon Globocare Corp is ALBT.
What is the 52-week high of Avalon Globocare Corp?
The 52-week high of Avalon Globocare Corp is 11.660.
What is the 52-week low of Avalon Globocare Corp?
The 52-week low of Avalon Globocare Corp is 0.878.
What is the market capitalization of Avalon Globocare Corp?
The market capitalization of Avalon Globocare Corp is 5.16M.
What is the net income of Avalon Globocare Corp?
The net income of Avalon Globocare Corp is -7.90M.
Is Avalon Globocare Corp (ALBT) currently rated as Buy, Hold, or Sell?
According to analysts, Avalon Globocare Corp (ALBT) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Avalon Globocare Corp (ALBT)?
The Earnings Per Share (EPS TTM) of Avalon Globocare Corp (ALBT) is -8.090.